Prazer’s proprietary TPD platform, selective protein degradation enabling moiety (SPiDEM), allows the rational design and rapid optimization of orally available and BBB-penetrating small molecules.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback